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Letter to the Editor
signal void which will extend past the tip of the electrode. There-
fore, since the positioning error in this paper was only measured 
in-plane, a fairer comparison would be to compare this to the in-
plane fusion error. For neuroinspireTM fusion software, for exam-
ple, this error would be 0.4 mm, which is less than the 0.7 mm 
distance quoted with the post-implantation MRI technique [6, 7]. 
Thus, the localisation error in using post-operative MRI, while 
small, is still greater than the fusion error achievable with the cur-
rent state-of-the-art software packages due to the large variable 
electrode artefact seen on MRI, somewhere within which the ac-
tual contact lies.
With respect to MRI safety and DBS, some manufacturers now 
have DBS systems (e.g., Medtronic Activa and Boston Scientific 
Vercise Gevia) which are deemed safe for post-implantation MRI 
at 1.5-T under certain specific conditions. Clearly, the experience 
of the MRI physicist and the neuroradiologist is critical in imple-
menting these conditions correctly to make the scan safe, an im-
portant consideration as such expertise may not be readily avail-
able at every DBS centre. Similarly, although 3-T MRI has been 
demonstrated to be safe in certain units in patients with implanted 
DBS systems, the results reported to date do not necessarily gen-
eralise to other scanners with different radiofrequency coil designs, 
and there are still ongoing concerns regarding its safety with no 
DBS manufacturer recommending this presently [8, 10]. 
Stereotactic localisation of DBS electrodes is an inherent com-
ponent of the surgical process. The debate on the best means of 
achieving this is likely to continue. Post-implantation MRI and 
stereotactic post-operative CT fused with stereotactic pre-opera-
tive MRI both offer viable alternatives for post-operative verifica-
tion of the electrode position, with an in-plane accuracy of within 
1 mm. However, in our view, stereotactic CT fused with pre-oper-
ative stereotactic MRI offers advantages in terms of a safer, faster, 
and less expensive examination, with an accuracy that is arguably 
comparable to or even slightly better than that of post-implanta-
tion stereotactic MRI, when state-of-the-art fusion algorithms are 
applied.
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Precise deep brain stimulator (DBS) lead and contact position-
ing is crucial for the therapeutic success of the procedure. Post-
operative localisation imaging is therefore essential to verify the 
electrode position and avoid the need for additional repositioning 
surgery at a later date. Verification may be done by image fusion 
of the pre-operative stereotactic magnetic resonance imaging 
(MRI) with a post-implantation stereotactic computed tomogra-
phy (CT) image or, alternatively, by stereotactic post-operative 
MRI. There is a debate on the choice of the best modality. The ad-
vantages of stereotactic MRI/CT fusion include direct visualisation 
of the metallic electrode contact with high-resolution CT, fast ac-
quisition time of CT important for the comfort of awake patients 
and the safety of those undergoing surgery with a general anaes-
thetic, and the reduced costs of CT compared to MRI. This is in 
contrast to the inherent safety concerns of MRI in the presence of 
DBS electrodes, and the artefact limitations of a large eccentric sig-
nal void around the contacts which is seen on MRI as the contact 
itself cannot be directly visualised [1]. The main advantage of post-
implantation stereotactic MRI is bypassing the need for post-im-
plantation image fusion with the associated errors that fusion al-
gorithms can introduce [2]. In recent years, however, continual 
improvements in CT/MRI fusion algorithms for the localisation of 
electrode placement have enabled post-implantation CT fused 
with pre-operative MRI to offer an accurate, reliable, and safe mo-
dality for assessing the anatomic location of DBS electrodes and 
active contacts [3–6].
Several recent papers have supported the use of post-implanta-
tion stereotactic MRI in DBS lead verification, addressing both the 
geometry of the electrode artefact and the safety concerns [7–9]. 
Hyam et al. [7] suggested that the lead hypointensity seen on post-
implantation stereotactic MRI is an accurate representation of its 
real location within deep brain structures. However, in their paper, 
they assumed zero positioning error on the z-axis on post-opera-
tive MRI when comparing this to the literature values for the fusion 
accuracy, and this assumption is open to question. The electrodes 
cause through-plane as well as in-plane dephasing, resulting in a 
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